Skip to main content
OpenTrials
Completed

NCT Number: NCT06689579

Unipolar vs Bipolar Hemiarthroplasty for Hip Fracture

The purpose of this study is to determine whether significant functional benefits are seen in patients who have a bipolar hemiarthroplasty as treatment for hip fracture compared to those who have a unipolar hemiarthroplasty.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Royal Infirmary Edinburgh

Edinburgh, Lothian, EH164SA, United Kingdom

About this study

Proposed study design

Randomized controlled trial of unipolar vs bipolar hip hemiarthroplasty for intracapsular fracture of the femoral neck

The trial will be conducted in accordance with the GCP (Good Clinical Practice) guidelines and will be reported in line with the CONSORT statement

Study Centre

The Royal Infirmary of Edinburgh admits 1000 patients a year with a hip fracture; the largest number in any one centre in Scotland. Of these, 500 have intracapsular fractures, which is the type addressed in this study. Some patients will be better suited to a total hip replacement (5-10% of this group), and others may refuse to consent to the trial (previous experience has suggested a rate of 15-20%). Investigators therefore expect just over 300 patients to be recruitable each year, and so plan to allow up to two years for recruitment, and two years to complete follow up of the last patient

Brief Study Method

  • Patients will be identified as requiring a hemiarthroplasty for an intracapsular fracture of the femoral neck
  • Patients will be asked to consent to recruitment to study. Consent by attorney or nearest relative for patients with cognitive impairment
  • Surgery performed via anterolateral approach on standard trauma list. Standard cemented stem implanted.
  • Patient randomized in theatre to receive a unipolar or bipolar hemiarthroplasty head.
  • Tantalum beads will be implanted within the bone of the femur and pelvis (not the hip joint) by a consultant surgeon investigator when operating or assisting personally. These will not implanted where an unsupervised trainee is performing surgery. Fifty patients in each group will have these implants.
  • Patients undergo standard rehabilitation: physiotherapy, occupational therapy and geriatrician services as required.
  • Standard pre-op, post-op and one-year and two-year plain pelvic radiographs will be obtained.
  • Subset of patients: Fifty patients who have received a bipolar hemiarthroplasty will be asked to undergo one additional x-ray of the hip at two years to assess the function of the device.
  • Functional assessment: patients will undergo the Timed up-and-go (TUG) test, physiological measurements of hip muscle recruitment and function, and standardized questionnaires (SF12 and Harris Hip score).

Power analysis and number of patients

200 patients in each arm of study (total 400) allowing for expected 27% mortality at one year.

DMC (Data Monitoring Committee)

A data monitoring committee will review the results during the study period to allow the project to be terminated if statistical significance is reached or if there are any untoward events.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted with an intracapsular fracture of the femoral neck who are suitable for a hemiarthroplasty.

Exclusion criteria

  • Patients deemed suitable for a total hip arthroplasty, patients with a high energy fracture.

Treatment and study plan

Unipolar hemiarthroplasty

Device

Other names: C Stem AMT Unipolar Hemi Arthroplasty DePuy Synthes

Bipolar hemiarthroplasty

Device

Other names: C Stem AMT Bipolar Hemi Arthroplasty DePuy Synthes

Primary outcomes

  1. Pain

    Time frame: 1 year

    visual analogue scale pain score ( on a 10cm baseline fro 'no pain' to 'worst pain imaginable'

Secondary outcomes

  1. Pain

    Time frame: 2 years

    visual analogue scale pain score ( on a 10cm baseline fro 'no pain' to 'worst pain imaginable'

  2. Function

    Time frame: 1 year

    as assessed by 'timed up and go test',

  3. Radiographic assessment

    Time frame: 1 year

    year evidence of acetabular erosion measured with radiostereometric assessment (RSA)

  4. Complications

    Time frame: intraoperative

    duration of surgery (minutes)

  5. Function

    Time frame: 1 year

    physical examination of range of motion

  6. Function

    Time frame: 2 years

    physical examination of range of motion

  7. Function and self care

    Time frame: 1 year

    Barthel Index

  8. Function and self care

    Time frame: 2 years

    Barthel Index

  9. Function and general health

    Time frame: 1 year

    Short form 12

  10. Function and general health

    Time frame: 2 years

    Short form 12

  11. Function

    Time frame: 1 year

    Harris Hip Score

  12. Function

    Time frame: 2 years

    Harris Hip Score

  13. Complications

    Time frame: up to 2 years

    presence of surgical site infection

  14. complications

    Time frame: up to 2 years

    Deep venous thorombosis

  15. complication

    Time frame: up to 2 years

    Periprosthetic fracture

  16. Complication

    Time frame: up to 2 years

    prosthesis dislocation

  17. Complication

    Time frame: up to 2 years

    implant failure

  18. complication

    Time frame: up to 2 years

    repoeration any cause

  19. Complication

    Time frame: up to 2 years

    death

  20. Function

    Time frame: 2 years

    as assessed by 'timed up and go test',

Sponsors and collaborators

Lead sponsor

NHS Lothian

Other Gov

Registry information

Official study title

Prospective Randomised Controlled Trial of Unipolar vs Bipolar Hemiarthroplasty for Patients With an Intracapsular Hip Fracture

Important dates

Study start
2014
Primary completion
2019
Study completion
2019
First posted
Nov 14, 2024
Registry last updated
Nov 14, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.